Does STAVUDINE Cause Neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm progression have been filed in association with STAVUDINE. This represents 0.4% of all adverse event reports for STAVUDINE.
9
Reports of Neoplasm progression with STAVUDINE
0.4%
of all STAVUDINE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From STAVUDINE?
Of the 9 reports, 6 (66.7%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STAVUDINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does STAVUDINE Cause?
Virologic failure (408)
Drug resistance (361)
Foetal exposure during pregnancy (343)
Lipodystrophy acquired (283)
Viral mutation identified (258)
Treatment failure (255)
Pathogen resistance (196)
Mitochondrial toxicity (180)
Eyelid ptosis (168)
Diplopia (166)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which STAVUDINE Alternatives Have Lower Neoplasm progression Risk?
STAVUDINE vs STELARA
STAVUDINE vs STIRIPENTOL
STAVUDINE vs STIVARGA
STAVUDINE vs STRATTERA
STAVUDINE vs STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A